Sfoglia per AUTORE
MILAZZO L
Collezione ASL Città di Torino

  

Items : 4

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.
2018
ASL Città di Torino

Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Sollima S; Gubertini G; Niero F; Saracino A; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Mastroianni C; Di Perri G; Bigoni S; Puoti M; Spinetti A; Gori A; Boffa N; Cacopardo B; Giacometti A; Parruti G; Vullo V; Chirianni A; et alii...

Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2016 Jul 15;63(2):285-6. doi: 10.1093/cid/ciw292. Epub 2016 May 3.
2016
ASL Città di Torino

Sollima S; D'Avolio A; Cattaneo D; Micheli V; Milazzo L; Gervasoni C;

Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 May;45(5):545-9. doi: 10.1016/j.ijantimicag.2014.12.035. Epub 2015 Feb
2015
ASL Città di Torino

Milazzo L; Cattaneo D; Calvi E; Gervasoni C; Mazzali C; Ronzi P; Peri AM; Ridolfo AL; D'Avolio A; Antinori S;

SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Apr;70(4):1155-60. doi: 10.1093/jac/dku519. Epub 2015 Jan 11.
2015
ASL Città di Torino

Milazzo L; Peri AM; Mazzali C; Magni C; Calvi E; De Nicolò A; Clementi E; Cheli S; D'Avolio A; Antinori S; Falvella FS;